| 0 |
GAMING DISORDER |
4 |
0.2105 |
| 1 |
POOR SCHOOL ATTENDANCE |
4 |
0.1600 |
| 2 |
DISRUPTIVE MOOD DYSREGULATION DISORDER |
7 |
0.0946 |
| 3 |
MACULAR DETACHMENT |
18 |
0.0744 |
| 4 |
SELECTIVE MUTISM |
6 |
0.0714 |
| 5 |
INTERMITTENT EXPLOSIVE DISORDER |
8 |
0.0684 |
| 6 |
OPPOSITIONAL DEFIANT DISORDER |
24 |
0.0608 |
| 7 |
ANTICHOLINERGIC EFFECT |
4 |
0.0533 |
| 8 |
DEFIANT BEHAVIOUR |
16 |
0.0519 |
| 9 |
ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED |
4 |
0.0426 |
| 10 |
FORCED EXPIRATORY VOLUME ABNORMAL |
6 |
0.0414 |
| 11 |
FOETAL ALCOHOL SYNDROME |
4 |
0.0400 |
| 12 |
WITHDRAWAL HYPERTENSION |
8 |
0.0396 |
| 13 |
ATRIOVENTRICULAR DISSOCIATION |
7 |
0.0327 |
| 14 |
RESTLESS LEG AUGMENTATION SYNDROME |
5 |
0.0323 |
| 15 |
CHOROIDAL EFFUSION |
22 |
0.0274 |
| 16 |
SELF-DESTRUCTIVE BEHAVIOUR |
23 |
0.0264 |
| 17 |
NEGATIVISM |
19 |
0.0250 |
| 18 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
59 |
0.0250 |
| 19 |
FRACTIONAL EXHALED NITRIC OXIDE INCREASED |
4 |
0.0223 |
| 20 |
EDUCATIONAL PROBLEM |
37 |
0.0222 |
| 21 |
GRANDIOSITY |
8 |
0.0219 |
| 22 |
IMPULSIVE BEHAVIOUR |
79 |
0.0210 |
| 23 |
TIC |
114 |
0.0209 |
| 24 |
HYPERTENSIVE URGENCY |
11 |
0.0199 |
| 25 |
BODY MASS INDEX DECREASED |
9 |
0.0194 |
| 26 |
CONDUCT DISORDER |
4 |
0.0194 |
| 27 |
VENTRICULAR DYSKINESIA |
4 |
0.0192 |
| 28 |
ZINC DEFICIENCY |
4 |
0.0186 |
| 29 |
ELECTROCARDIOGRAM T WAVE PEAKED |
7 |
0.0174 |
| 30 |
ACTIVATION SYNDROME |
6 |
0.0173 |
| 31 |
TRICHOTILLOMANIA |
10 |
0.0171 |
| 32 |
DRUG-GENETIC INTERACTION |
6 |
0.0168 |
| 33 |
ELECTROCARDIOGRAM QT SHORTENED |
5 |
0.0165 |
| 34 |
NEPHROGENIC DIABETES INSIPIDUS |
19 |
0.0165 |
| 35 |
OROMANDIBULAR DYSTONIA |
12 |
0.0165 |
| 36 |
DISTRACTIBILITY |
17 |
0.0147 |
| 37 |
GROWTH FAILURE |
5 |
0.0145 |
| 38 |
ORTHOSTATIC INTOLERANCE |
10 |
0.0139 |
| 39 |
DERMATILLOMANIA |
8 |
0.0134 |
| 40 |
CHANGE IN SUSTAINED ATTENTION |
4 |
0.0133 |
| 41 |
SEROUS RETINAL DETACHMENT |
11 |
0.0131 |
| 42 |
DRUG DOSE TITRATION NOT PERFORMED |
24 |
0.0131 |
| 43 |
SINUS ARRHYTHMIA |
17 |
0.0130 |
| 44 |
CARDIOVASCULAR SYMPTOM |
5 |
0.0129 |
| 45 |
ANION GAP |
8 |
0.0126 |
| 46 |
INCORRECT PRODUCT DOSAGE FORM ADMINISTERED |
5 |
0.0119 |
| 47 |
BRUGADA SYNDROME |
12 |
0.0116 |
| 48 |
ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL |
5 |
0.0112 |
| 49 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
15 |
0.0111 |
| 50 |
PERIODIC LIMB MOVEMENT DISORDER |
4 |
0.0109 |
| 51 |
CHOROIDAL DETACHMENT |
6 |
0.0108 |
| 52 |
BEHAVIOUR DISORDER |
57 |
0.0105 |
| 53 |
HEAD BANGING |
6 |
0.0105 |
| 54 |
BRADYPNOEA |
28 |
0.0104 |
| 55 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
42 |
0.0100 |
| 56 |
MANUFACTURING MATERIALS ISSUE |
4 |
0.0099 |
| 57 |
AUTISM SPECTRUM DISORDER |
53 |
0.0096 |
| 58 |
SINUS ARREST |
15 |
0.0096 |
| 59 |
ENURESIS |
37 |
0.0092 |
| 60 |
UPPER AIRWAY OBSTRUCTION |
8 |
0.0090 |
| 61 |
GRIMACING |
7 |
0.0090 |
| 62 |
DISTRIBUTIVE SHOCK |
20 |
0.0088 |
| 63 |
EXCESSIVE EYE BLINKING |
13 |
0.0088 |
| 64 |
PSYCHOMOTOR HYPERACTIVITY |
145 |
0.0087 |
| 65 |
WOLFF-PARKINSON-WHITE SYNDROME |
4 |
0.0085 |
| 66 |
PATIENT UNCOOPERATIVE |
4 |
0.0084 |
| 67 |
HYPERTENSIVE ENCEPHALOPATHY |
5 |
0.0084 |
| 68 |
SUBRETINAL FLUID |
9 |
0.0082 |
| 69 |
VERBAL ABUSE |
4 |
0.0082 |
| 70 |
AGGRESSION |
399 |
0.0080 |
| 71 |
AUTISM |
8 |
0.0079 |
| 72 |
ADHESIVE TAPE USE |
3 |
0.0078 |
| 73 |
POSTURING |
4 |
0.0077 |
| 74 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
12 |
0.0077 |
| 75 |
HYPERTENSIVE EMERGENCY |
9 |
0.0076 |
| 76 |
SOCIAL ANXIETY DISORDER |
5 |
0.0076 |
| 77 |
ANTICHOLINERGIC SYNDROME |
12 |
0.0075 |
| 78 |
HALLUCINATION, TACTILE |
5 |
0.0075 |
| 79 |
SINUS BRADYCARDIA |
72 |
0.0074 |
| 80 |
STEREOTYPY |
7 |
0.0074 |
| 81 |
HOMICIDAL IDEATION |
30 |
0.0074 |
| 82 |
STARVATION |
6 |
0.0072 |
| 83 |
PROTRUSION TONGUE |
4 |
0.0069 |
| 84 |
VASOPLEGIA SYNDROME |
11 |
0.0067 |
| 85 |
ELECTROCARDIOGRAM QT PROLONGED |
235 |
0.0065 |
| 86 |
PHYSICAL ASSAULT |
13 |
0.0062 |
| 87 |
CHANGE IN SEIZURE PRESENTATION |
4 |
0.0062 |
| 88 |
ABNORMAL BEHAVIOUR |
229 |
0.0058 |
| 89 |
PHARYNGEAL PARAESTHESIA |
9 |
0.0057 |
| 90 |
HOSTILITY |
14 |
0.0055 |
| 91 |
SELECTIVE EATING DISORDER |
5 |
0.0055 |
| 92 |
SEDATION COMPLICATION |
14 |
0.0055 |
| 93 |
SELF-INJURIOUS IDEATION |
23 |
0.0055 |
| 94 |
DRUG EFFECT VARIABLE |
6 |
0.0053 |
| 95 |
INSULIN RESISTANCE |
11 |
0.0053 |
| 96 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
37 |
0.0052 |
| 97 |
BRADYCARDIA |
272 |
0.0051 |
| 98 |
TRANSCRIPTION MEDICATION ERROR |
8 |
0.0051 |
| 99 |
INTRUSIVE THOUGHTS |
6 |
0.0051 |
| 100 |
DRUG EFFECT INCREASED |
16 |
0.0051 |
| 101 |
CARDIAC ANEURYSM |
5 |
0.0050 |
| 102 |
STARING |
12 |
0.0050 |
| 103 |
INTENTIONAL SELF-INJURY |
100 |
0.0049 |
| 104 |
PRIAPISM |
17 |
0.0049 |
| 105 |
LOGORRHOEA |
17 |
0.0048 |
| 106 |
JUDGEMENT IMPAIRED |
7 |
0.0048 |
| 107 |
GROWTH RETARDATION |
14 |
0.0048 |
| 108 |
HYPOPROTEINAEMIA |
9 |
0.0047 |
| 109 |
ANGER |
155 |
0.0046 |
| 110 |
CATATONIA |
24 |
0.0046 |
| 111 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
4 |
0.0045 |
| 112 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
13 |
0.0044 |
| 113 |
INHIBITORY DRUG INTERACTION |
7 |
0.0044 |
| 114 |
HYPERAMMONAEMIA |
22 |
0.0044 |
| 115 |
SCREAMING |
28 |
0.0044 |
| 116 |
ABULIA |
4 |
0.0043 |
| 117 |
INTENTIONAL OVERDOSE |
275 |
0.0043 |
| 118 |
MAST CELL ACTIVATION SYNDROME |
6 |
0.0043 |
| 119 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
29 |
0.0043 |
| 120 |
HYPORESPONSIVE TO STIMULI |
5 |
0.0043 |
| 121 |
AFFECTIVE DISORDER |
33 |
0.0042 |
| 122 |
SLEEP TALKING |
7 |
0.0041 |
| 123 |
OBSESSIVE-COMPULSIVE DISORDER |
33 |
0.0041 |
| 124 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
25 |
0.0041 |
| 125 |
AFFECT LABILITY |
39 |
0.0040 |
| 126 |
DRUG TOLERANCE |
20 |
0.0039 |
| 127 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
20 |
0.0039 |
| 128 |
SEDATION |
102 |
0.0039 |
| 129 |
IMMUNE THROMBOCYTOPENIC PURPURA |
11 |
0.0039 |
| 130 |
IMPULSE-CONTROL DISORDER |
8 |
0.0039 |
| 131 |
DISINHIBITION |
6 |
0.0037 |
| 132 |
PRODUCT ADMINISTRATION INTERRUPTED |
29 |
0.0037 |
| 133 |
DYSPHEMIA |
16 |
0.0036 |
| 134 |
BIPOLAR I DISORDER |
8 |
0.0036 |
| 135 |
STRESS CARDIOMYOPATHY |
21 |
0.0036 |
| 136 |
EOSINOPHILIC OESOPHAGITIS |
10 |
0.0036 |
| 137 |
SELF INJURIOUS BEHAVIOUR |
11 |
0.0036 |
| 138 |
SLEEP TERROR |
15 |
0.0036 |
| 139 |
DARK CIRCLES UNDER EYES |
5 |
0.0034 |
| 140 |
PSYCHOTIC SYMPTOM |
7 |
0.0034 |
| 141 |
SUICIDAL BEHAVIOUR |
14 |
0.0034 |
| 142 |
SLEEP DEFICIT |
7 |
0.0033 |
| 143 |
FORCED EXPIRATORY VOLUME DECREASED |
9 |
0.0032 |
| 144 |
SEROTONIN SYNDROME |
61 |
0.0032 |
| 145 |
INAPPROPRIATE AFFECT |
5 |
0.0032 |
| 146 |
PRODUCT SUBSTITUTION ISSUE |
178 |
0.0031 |
| 147 |
BICYTOPENIA |
6 |
0.0031 |
| 148 |
NEPHROGENIC ANAEMIA |
14 |
0.0030 |
| 149 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
10 |
0.0030 |
| 150 |
TROPONIN I INCREASED |
5 |
0.0030 |
| 151 |
DIZZINESS POSTURAL |
29 |
0.0030 |
| 152 |
SUICIDAL IDEATION |
271 |
0.0030 |
| 153 |
IRRITABILITY |
178 |
0.0030 |
| 154 |
GAZE PALSY |
5 |
0.0029 |
| 155 |
CARBON DIOXIDE INCREASED |
4 |
0.0029 |
| 156 |
LONG QT SYNDROME |
7 |
0.0029 |
| 157 |
LEARNING DISORDER |
7 |
0.0029 |
| 158 |
SOCIAL PROBLEM |
12 |
0.0029 |
| 159 |
WRONG DOSE |
7 |
0.0029 |
| 160 |
DROOLING |
20 |
0.0029 |
| 161 |
TACHYPHRENIA |
10 |
0.0029 |
| 162 |
DYSTONIA |
56 |
0.0029 |
| 163 |
HEART RATE ABNORMAL |
16 |
0.0029 |
| 164 |
INFUSION SITE DISCHARGE |
5 |
0.0028 |
| 165 |
FRUSTRATION TOLERANCE DECREASED |
23 |
0.0028 |
| 166 |
TORTICOLLIS |
6 |
0.0028 |
| 167 |
TONIC CONVULSION |
4 |
0.0028 |
| 168 |
AGITATION |
207 |
0.0028 |
| 169 |
MANIA |
46 |
0.0028 |
| 170 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
15 |
0.0028 |
| 171 |
NEGATIVE THOUGHTS |
8 |
0.0027 |
| 172 |
DISTURBANCE IN ATTENTION |
147 |
0.0027 |
| 173 |
DRUG TITRATION ERROR |
7 |
0.0027 |
| 174 |
DRUG PRESCRIBING ERROR |
52 |
0.0027 |
| 175 |
SKIN STRIAE |
4 |
0.0027 |
| 176 |
PERSONALITY DISORDER |
7 |
0.0027 |
| 177 |
INITIAL INSOMNIA |
27 |
0.0026 |
| 178 |
FLAT AFFECT |
6 |
0.0026 |
| 179 |
VIOLENCE-RELATED SYMPTOM |
4 |
0.0026 |
| 180 |
BLOOD CREATININE DECREASED |
8 |
0.0026 |
| 181 |
DEPRESSIVE SYMPTOM |
9 |
0.0026 |
| 182 |
INFUSION SITE PRURITUS |
8 |
0.0025 |
| 183 |
EMOTIONAL DISORDER |
78 |
0.0025 |
| 184 |
INABILITY TO AFFORD MEDICATION |
25 |
0.0025 |
| 185 |
INCREASED APPETITE |
48 |
0.0025 |
| 186 |
HYPERPHAGIA |
10 |
0.0025 |
| 187 |
BIPOLAR DISORDER |
27 |
0.0025 |
| 188 |
SELF ESTEEM DECREASED |
6 |
0.0025 |
| 189 |
ORTHOSTATIC HYPOTENSION |
43 |
0.0025 |
| 190 |
HALLUCINATION, AUDITORY |
39 |
0.0025 |
| 191 |
NEUROLEPTIC MALIGNANT SYNDROME |
29 |
0.0024 |
| 192 |
THERAPY CHANGE |
24 |
0.0024 |
| 193 |
CARDIAC DYSFUNCTION |
9 |
0.0024 |
| 194 |
DRUG LEVEL ABOVE THERAPEUTIC |
11 |
0.0024 |
| 195 |
PULSELESS ELECTRICAL ACTIVITY |
10 |
0.0024 |
| 196 |
CONTRAINDICATED PRODUCT PRESCRIBED |
4 |
0.0024 |
| 197 |
SOMNOLENCE |
479 |
0.0024 |
| 198 |
HALLUCINATIONS, MIXED |
10 |
0.0024 |
| 199 |
SUSPECTED SUICIDE |
11 |
0.0023 |
| 200 |
THERAPEUTIC PRODUCT INEFFECTIVE |
9 |
0.0023 |
| 201 |
GYNAECOMASTIA |
72 |
0.0023 |
| 202 |
MEDICATION RESIDUE PRESENT |
11 |
0.0023 |
| 203 |
CEREBRAL DISORDER |
17 |
0.0023 |
| 204 |
SOMNAMBULISM |
15 |
0.0023 |
| 205 |
DRUG WITHDRAWAL CONVULSIONS |
4 |
0.0022 |
| 206 |
PRE-EXISTING CONDITION IMPROVED |
14 |
0.0022 |
| 207 |
DISSOCIATION |
17 |
0.0022 |
| 208 |
THERAPEUTIC RESPONSE CHANGED |
14 |
0.0022 |
| 209 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
21 |
0.0022 |
| 210 |
AGORAPHOBIA |
3 |
0.0022 |
| 211 |
HYPOMANIA |
8 |
0.0022 |
| 212 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
79 |
0.0022 |
| 213 |
REACTION TO EXCIPIENT |
5 |
0.0022 |
| 214 |
HYPERTRICHOSIS |
4 |
0.0022 |
| 215 |
LISTLESS |
7 |
0.0021 |
| 216 |
NARCOLEPSY |
4 |
0.0021 |
| 217 |
PRODUCT AVAILABILITY ISSUE |
48 |
0.0021 |
| 218 |
ANXIETY DISORDER |
7 |
0.0021 |
| 219 |
TEARFULNESS |
9 |
0.0021 |
| 220 |
BLOOD PRESSURE DECREASED |
138 |
0.0021 |
| 221 |
LETHARGY |
119 |
0.0021 |
| 222 |
CONVERSION DISORDER |
4 |
0.0021 |
| 223 |
HALLUCINATION, VISUAL |
43 |
0.0020 |
| 224 |
SUICIDE ATTEMPT |
123 |
0.0020 |
| 225 |
DRUG DELIVERY SYSTEM ISSUE |
4 |
0.0020 |
| 226 |
HYPERPROLACTINAEMIA |
13 |
0.0020 |
| 227 |
PERSECUTORY DELUSION |
5 |
0.0020 |
| 228 |
RECALLED PRODUCT ADMINISTERED |
19 |
0.0020 |
| 229 |
CRANIOCEREBRAL INJURY |
6 |
0.0020 |
| 230 |
SUDDEN HEARING LOSS |
4 |
0.0020 |
| 231 |
HYPOTHERMIA |
20 |
0.0020 |
| 232 |
PRESCRIBED OVERDOSE |
38 |
0.0020 |
| 233 |
RESPIRATORY DEPRESSION |
24 |
0.0020 |
| 234 |
MOOD SWINGS |
62 |
0.0019 |
| 235 |
POST-TRAUMATIC STRESS DISORDER |
13 |
0.0019 |
| 236 |
BLOOD PROLACTIN INCREASED |
9 |
0.0019 |
| 237 |
ABNORMAL LOSS OF WEIGHT |
13 |
0.0019 |
| 238 |
MOOD ALTERED |
52 |
0.0019 |
| 239 |
DEVICE MATERIAL ISSUE |
4 |
0.0019 |
| 240 |
SOCIAL AVOIDANT BEHAVIOUR |
11 |
0.0019 |
| 241 |
RESTLESSNESS |
69 |
0.0019 |
| 242 |
APPLICATION SITE ERYTHEMA |
49 |
0.0019 |
| 243 |
APPLICATION SITE SCAB |
4 |
0.0019 |
| 244 |
SNORING |
7 |
0.0018 |
| 245 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
8 |
0.0018 |
| 246 |
GENERALISED TONIC-CLONIC SEIZURE |
30 |
0.0018 |
| 247 |
ATRIOVENTRICULAR BLOCK |
14 |
0.0018 |
| 248 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
7 |
0.0018 |
| 249 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
19 |
0.0018 |
| 250 |
CARDIAC FAILURE ACUTE |
12 |
0.0018 |
| 251 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
4 |
0.0018 |
| 252 |
DYSPHORIA |
9 |
0.0018 |
| 253 |
SUPRAVENTRICULAR EXTRASYSTOLES |
6 |
0.0018 |
| 254 |
PETIT MAL EPILEPSY |
9 |
0.0018 |
| 255 |
SYNCOPE |
176 |
0.0018 |
| 256 |
AKATHISIA |
24 |
0.0018 |
| 257 |
BUNDLE BRANCH BLOCK RIGHT |
8 |
0.0017 |
| 258 |
HYPERTONIC BLADDER |
5 |
0.0017 |
| 259 |
MIDDLE INSOMNIA |
32 |
0.0017 |
| 260 |
DRUG ADMINISTRATION ERROR |
52 |
0.0017 |
| 261 |
PSYCHOTIC DISORDER |
50 |
0.0017 |
| 262 |
WITHDRAWAL SYNDROME |
71 |
0.0017 |
| 263 |
PRODUCT PREPARATION ISSUE |
11 |
0.0017 |
| 264 |
INFUSION SITE REACTION |
5 |
0.0017 |
| 265 |
APPETITE DISORDER |
11 |
0.0017 |
| 266 |
REBOUND ACID HYPERSECRETION |
5 |
0.0017 |
| 267 |
BLOOD IMMUNOGLOBULIN E INCREASED |
4 |
0.0017 |
| 268 |
INCORRECT DRUG ADMINISTRATION DURATION |
46 |
0.0016 |
| 269 |
PARADOXICAL DRUG REACTION |
6 |
0.0016 |
| 270 |
ABNORMAL WEIGHT GAIN |
20 |
0.0016 |
| 271 |
ALTERED STATE OF CONSCIOUSNESS |
35 |
0.0016 |
| 272 |
HYPERACUSIS |
6 |
0.0016 |
| 273 |
APPLICATION SITE IRRITATION |
20 |
0.0016 |
| 274 |
DEVICE MECHANICAL ISSUE |
22 |
0.0016 |
| 275 |
PRESYNCOPE |
39 |
0.0016 |
| 276 |
RESPIRATORY RATE DECREASED |
5 |
0.0016 |
| 277 |
ELECTROENCEPHALOGRAM ABNORMAL |
5 |
0.0016 |
| 278 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
62 |
0.0016 |
| 279 |
MYDRIASIS |
20 |
0.0016 |
| 280 |
TRISMUS |
8 |
0.0015 |
| 281 |
PRODUCT QUALITY ISSUE |
210 |
0.0015 |
| 282 |
PALLOR |
42 |
0.0015 |
| 283 |
CRYING |
56 |
0.0015 |
| 284 |
THERAPY PARTIAL RESPONDER |
24 |
0.0015 |
| 285 |
RESPIRATORY ACIDOSIS |
6 |
0.0015 |
| 286 |
INFUSION SITE HAEMORRHAGE |
5 |
0.0015 |
| 287 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
5 |
0.0015 |
| 288 |
THIRST |
27 |
0.0015 |
| 289 |
HYPOTENSION |
303 |
0.0015 |
| 290 |
PERSONALITY CHANGE |
14 |
0.0015 |
| 291 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
0.0015 |
| 292 |
AREFLEXIA |
4 |
0.0015 |
| 293 |
PRODUCT RESIDUE PRESENT |
8 |
0.0015 |
| 294 |
BRUXISM |
8 |
0.0015 |
| 295 |
DELUSION |
23 |
0.0015 |
| 296 |
PHARYNGITIS STREPTOCOCCAL |
16 |
0.0015 |
| 297 |
PRODUCT DISPENSING ERROR |
32 |
0.0015 |
| 298 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
9 |
0.0015 |
| 299 |
PERIPHERAL COLDNESS |
20 |
0.0015 |
| 300 |
HEART RATE DECREASED |
51 |
0.0015 |
| 301 |
AKINESIA |
3 |
0.0014 |
| 302 |
TOXICITY TO VARIOUS AGENTS |
244 |
0.0014 |
| 303 |
SEIZURE |
167 |
0.0014 |
| 304 |
DRUG SCREEN FALSE POSITIVE |
4 |
0.0014 |
| 305 |
CYSTIC FIBROSIS |
8 |
0.0014 |
| 306 |
MUSCLE TWITCHING |
33 |
0.0014 |
| 307 |
ELECTRIC SHOCK SENSATION |
4 |
0.0014 |
| 308 |
DRUG TOLERANCE DECREASED |
4 |
0.0014 |
| 309 |
PRODUCT CONTAMINATION |
5 |
0.0014 |
| 310 |
GALACTORRHOEA |
9 |
0.0014 |
| 311 |
SALIVARY HYPERSECRETION |
14 |
0.0014 |
| 312 |
PARANOIA |
24 |
0.0014 |
| 313 |
PRODUCT PHYSICAL ISSUE |
28 |
0.0014 |
| 314 |
HYPERVENTILATION |
8 |
0.0014 |
| 315 |
INSURANCE ISSUE |
21 |
0.0014 |
| 316 |
APATHY |
20 |
0.0014 |
| 317 |
ACCIDENTAL OVERDOSE |
50 |
0.0014 |
| 318 |
DEPRESSED MOOD |
72 |
0.0014 |
| 319 |
DRUG EFFECT LESS THAN EXPECTED |
20 |
0.0013 |
| 320 |
MENTAL DISORDER |
58 |
0.0013 |
| 321 |
WRONG PRODUCT ADMINISTERED |
9 |
0.0013 |
| 322 |
DYSARTHRIA |
50 |
0.0013 |
| 323 |
HYPERSOMNIA |
38 |
0.0013 |
| 324 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
4 |
0.0013 |
| 325 |
OBESITY |
21 |
0.0013 |
| 326 |
EYE MOVEMENT DISORDER |
9 |
0.0013 |
| 327 |
TROPONIN INCREASED |
10 |
0.0013 |
| 328 |
ARRHYTHMIA |
62 |
0.0013 |
| 329 |
INFUSION SITE ERYTHEMA |
11 |
0.0013 |
| 330 |
OVERWEIGHT |
7 |
0.0013 |
| 331 |
HALLUCINATION |
98 |
0.0013 |
| 332 |
POOR QUALITY DEVICE USED |
13 |
0.0013 |
| 333 |
FORMICATION |
9 |
0.0013 |
| 334 |
RHINOVIRUS INFECTION |
5 |
0.0013 |
| 335 |
EPILEPSY |
39 |
0.0013 |
| 336 |
SINUS TACHYCARDIA |
18 |
0.0013 |
| 337 |
TREATMENT FAILURE |
105 |
0.0013 |
| 338 |
BRAIN OEDEMA |
16 |
0.0013 |
| 339 |
POLYDIPSIA |
5 |
0.0013 |
| 340 |
MUSCLE RIGIDITY |
15 |
0.0013 |
| 341 |
MIOSIS |
10 |
0.0012 |
| 342 |
DRUG INTERACTION |
193 |
0.0012 |
| 343 |
ACUTE PSYCHOSIS |
3 |
0.0012 |
| 344 |
PRODUCT FORMULATION ISSUE |
8 |
0.0012 |
| 345 |
NEAR DEATH EXPERIENCE |
4 |
0.0012 |
| 346 |
EXPIRED DEVICE USED |
4 |
0.0012 |
| 347 |
UNRESPONSIVE TO STIMULI |
31 |
0.0012 |
| 348 |
ATRIOVENTRICULAR BLOCK COMPLETE |
8 |
0.0012 |
| 349 |
TACHYCARDIA |
106 |
0.0012 |
| 350 |
DECREASED INTEREST |
7 |
0.0012 |
| 351 |
ENERGY INCREASED |
7 |
0.0012 |
| 352 |
IMPAIRED QUALITY OF LIFE |
17 |
0.0012 |
| 353 |
ABNORMAL UTERINE BLEEDING |
3 |
0.0012 |
| 354 |
OBSTRUCTIVE AIRWAYS DISORDER |
13 |
0.0012 |
| 355 |
LEFT VENTRICULAR HYPERTROPHY |
5 |
0.0012 |
| 356 |
CEREBRAL ISCHAEMIA |
6 |
0.0012 |
| 357 |
CONCUSSION |
9 |
0.0012 |
| 358 |
APNOEA |
9 |
0.0012 |
| 359 |
HAIR GROWTH ABNORMAL |
8 |
0.0012 |
| 360 |
MENTAL IMPAIRMENT |
28 |
0.0012 |
| 361 |
REBOUND EFFECT |
13 |
0.0011 |
| 362 |
NO ADVERSE EVENT |
208 |
0.0011 |
| 363 |
DRUG LEVEL INCREASED |
19 |
0.0011 |
| 364 |
SENSITIVITY TO WEATHER CHANGE |
6 |
0.0011 |
| 365 |
THINKING ABNORMAL |
21 |
0.0011 |
| 366 |
INTENTIONAL DOSE OMISSION |
32 |
0.0011 |
| 367 |
PRODUCT SUPPLY ISSUE |
8 |
0.0011 |
| 368 |
FRUSTRATION |
4 |
0.0011 |
| 369 |
INSOMNIA |
297 |
0.0011 |
| 370 |
INFUSION SITE SWELLING |
7 |
0.0011 |
| 371 |
DYSKINESIA |
45 |
0.0011 |
| 372 |
DRUG EFFECT DELAYED |
5 |
0.0011 |
| 373 |
IMPAIRED GASTRIC EMPTYING |
15 |
0.0011 |
| 374 |
BLOOD PRESSURE SYSTOLIC DECREASED |
5 |
0.0011 |
| 375 |
PSYCHIATRIC SYMPTOM |
8 |
0.0011 |
| 376 |
STREPTOCOCCAL INFECTION |
6 |
0.0011 |
| 377 |
COMA |
51 |
0.0011 |
| 378 |
CATHETER SITE INFECTION |
4 |
0.0011 |
| 379 |
SLEEP DISORDER |
74 |
0.0010 |
| 380 |
POOR QUALITY SLEEP |
22 |
0.0010 |
| 381 |
DRUG EFFECT DECREASED |
55 |
0.0010 |
| 382 |
BRAIN FOG |
16 |
0.0010 |
| 383 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
72 |
0.0010 |
| 384 |
SUSPECTED COUNTERFEIT PRODUCT |
4 |
0.0010 |
| 385 |
PRODUCT ADHESION ISSUE |
36 |
0.0010 |
| 386 |
MYOSITIS |
9 |
0.0010 |
| 387 |
ARTERIOSPASM CORONARY |
4 |
0.0010 |
| 388 |
BLINDNESS UNILATERAL |
14 |
0.0010 |
| 389 |
URINARY RETENTION |
33 |
0.0010 |
| 390 |
EATING DISORDER |
21 |
0.0010 |
| 391 |
ANXIETY |
280 |
0.0010 |
| 392 |
SUBSTANCE ABUSE |
8 |
0.0010 |
| 393 |
NIGHTMARE |
34 |
0.0010 |
| 394 |
SLUGGISHNESS |
10 |
0.0010 |
| 395 |
PRODUCT USE ISSUE |
184 |
0.0010 |
| 396 |
EUPHORIC MOOD |
10 |
0.0010 |
| 397 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
28 |
0.0010 |
| 398 |
PANIC REACTION |
7 |
0.0010 |
| 399 |
APPLICATION SITE PRURITUS |
22 |
0.0010 |
| 400 |
SCOLIOSIS |
6 |
0.0010 |
| 401 |
BENIGN PROSTATIC HYPERPLASIA |
5 |
0.0010 |
| 402 |
FEAR |
26 |
0.0010 |
| 403 |
RASH PUSTULAR |
7 |
0.0010 |
| 404 |
COMPLETED SUICIDE |
80 |
0.0010 |
| 405 |
MAJOR DEPRESSION |
7 |
0.0010 |
| 406 |
WEIGHT INCREASED |
214 |
0.0010 |
| 407 |
CYANOSIS |
15 |
0.0010 |
| 408 |
BLEPHAROSPASM |
6 |
0.0010 |
| 409 |
INCONTINENCE |
10 |
0.0009 |
| 410 |
URINARY INCONTINENCE |
28 |
0.0009 |
| 411 |
GASTROENTERITIS VIRAL |
17 |
0.0009 |
| 412 |
SEXUAL DYSFUNCTION |
11 |
0.0009 |
| 413 |
ENCEPHALOPATHY |
23 |
0.0009 |
| 414 |
PRODUCT DISPENSING ISSUE |
4 |
0.0009 |
| 415 |
SENSORY DISTURBANCE |
15 |
0.0009 |
| 416 |
ATAXIA |
11 |
0.0009 |
| 417 |
PARKINSONISM |
9 |
0.0009 |
| 418 |
CHAPPED LIPS |
4 |
0.0009 |
| 419 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 420 |
DEVICE PHYSICAL PROPERTY ISSUE |
7 |
0.0009 |
| 421 |
NONSPECIFIC REACTION |
5 |
0.0009 |
| 422 |
FOOD ALLERGY |
7 |
0.0009 |
| 423 |
EAR INFECTION |
24 |
0.0009 |
| 424 |
DEVICE INFORMATION OUTPUT ISSUE |
7 |
0.0009 |
| 425 |
ELECTROCARDIOGRAM ABNORMAL |
7 |
0.0009 |
| 426 |
LOSS OF CONSCIOUSNESS |
114 |
0.0009 |
| 427 |
PRODUCT USE COMPLAINT |
14 |
0.0009 |
| 428 |
STATUS EPILEPTICUS |
10 |
0.0009 |
| 429 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
4 |
0.0009 |
| 430 |
GRANULOCYTOPENIA |
5 |
0.0009 |
| 431 |
DERMATITIS CONTACT |
10 |
0.0009 |
| 432 |
CONVULSION |
50 |
0.0009 |
| 433 |
EXERCISE TOLERANCE DECREASED |
5 |
0.0009 |
| 434 |
GRAND MAL CONVULSION |
8 |
0.0009 |
| 435 |
BLOOD URIC ACID INCREASED |
5 |
0.0009 |
| 436 |
APPLICATION SITE PAIN |
19 |
0.0009 |
| 437 |
HUNGER |
12 |
0.0009 |
| 438 |
COGNITIVE DISORDER |
40 |
0.0009 |
| 439 |
INFUSION SITE PAIN |
11 |
0.0009 |
| 440 |
TARDIVE DYSKINESIA |
24 |
0.0008 |
| 441 |
RETCHING |
18 |
0.0008 |
| 442 |
PRODUCT ADMINISTRATION ERROR |
17 |
0.0008 |
| 443 |
PULSE ABSENT |
4 |
0.0008 |
| 444 |
TREATMENT NONCOMPLIANCE |
46 |
0.0008 |
| 445 |
FEELING JITTERY |
16 |
0.0008 |
| 446 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
46 |
0.0008 |
| 447 |
DECREASED ACTIVITY |
9 |
0.0008 |
| 448 |
VISUAL FIELD DEFECT |
6 |
0.0008 |
| 449 |
TYPE 1 DIABETES MELLITUS |
5 |
0.0008 |
| 450 |
INJECTION SITE VESICLES |
5 |
0.0008 |
| 451 |
LIQUID PRODUCT PHYSICAL ISSUE |
6 |
0.0008 |
| 452 |
HAEMORRHOIDAL HAEMORRHAGE |
4 |
0.0008 |
| 453 |
SKIN FISSURES |
16 |
0.0008 |
| 454 |
DECREASED APPETITE |
190 |
0.0008 |
| 455 |
RENAL CELL CARCINOMA |
4 |
0.0008 |
| 456 |
OVERDOSE |
176 |
0.0008 |
| 457 |
COELIAC DISEASE |
8 |
0.0008 |
| 458 |
HYPERHIDROSIS |
105 |
0.0008 |
| 459 |
DEVICE BREAKAGE |
33 |
0.0008 |
| 460 |
PRODUCT TASTE ABNORMAL |
11 |
0.0008 |
| 461 |
VENTRICULAR FIBRILLATION |
9 |
0.0008 |
| 462 |
SKIN HAEMORRHAGE |
12 |
0.0008 |
| 463 |
EXPIRED DRUG ADMINISTERED |
4 |
0.0008 |
| 464 |
MUCOUS STOOLS |
4 |
0.0008 |
| 465 |
DELIRIUM |
28 |
0.0008 |
| 466 |
FLUID INTAKE REDUCED |
4 |
0.0008 |
| 467 |
PANIC ATTACK |
29 |
0.0008 |
| 468 |
MENTAL STATUS CHANGES |
22 |
0.0008 |
| 469 |
DEPRESSION |
180 |
0.0008 |
| 470 |
DIABETIC KETOACIDOSIS |
19 |
0.0008 |
| 471 |
DRUG DISPENSING ERROR |
12 |
0.0008 |
| 472 |
CARDIOTOXICITY |
7 |
0.0008 |
| 473 |
PULMONARY OEDEMA |
35 |
0.0008 |
| 474 |
INCOHERENT |
5 |
0.0008 |
| 475 |
WEIGHT FLUCTUATION |
8 |
0.0008 |
| 476 |
BLOOD LACTIC ACID INCREASED |
4 |
0.0008 |
| 477 |
PRODUCT DISTRIBUTION ISSUE |
7 |
0.0008 |
| 478 |
NYSTAGMUS |
4 |
0.0008 |
| 479 |
LEFT VENTRICULAR DYSFUNCTION |
5 |
0.0007 |
| 480 |
BLOOD TRIGLYCERIDES INCREASED |
13 |
0.0007 |
| 481 |
OFF LABEL USE |
643 |
0.0007 |
| 482 |
BLOOD TESTOSTERONE DECREASED |
5 |
0.0007 |
| 483 |
ASPIRATION |
8 |
0.0007 |
| 484 |
EXTRAPYRAMIDAL DISORDER |
18 |
0.0007 |
| 485 |
DERMATITIS ATOPIC |
38 |
0.0007 |
| 486 |
ACCIDENTAL EXPOSURE |
3 |
0.0007 |
| 487 |
HYPERTENSIVE CRISIS |
8 |
0.0007 |
| 488 |
MOVEMENT DISORDER |
23 |
0.0007 |
| 489 |
CIRCULATORY COLLAPSE |
12 |
0.0007 |
| 490 |
BRAIN INJURY |
7 |
0.0007 |
| 491 |
CARDIOGENIC SHOCK |
10 |
0.0007 |
| 492 |
THERAPEUTIC RESPONSE SHORTENED |
23 |
0.0007 |
| 493 |
DIPLOPIA |
18 |
0.0007 |
| 494 |
METABOLIC DISORDER |
4 |
0.0007 |
| 495 |
DRUG LEVEL DECREASED |
7 |
0.0007 |
| 496 |
LACTIC ACIDOSIS |
22 |
0.0007 |
| 497 |
TEMPERATURE INTOLERANCE |
7 |
0.0007 |
| 498 |
DRY MOUTH |
55 |
0.0007 |
| 499 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
137 |
0.0007 |
| 500 |
FEELING DRUNK |
5 |
0.0007 |
| 501 |
DEVICE LEAKAGE |
29 |
0.0007 |
| 502 |
THERAPEUTIC RESPONSE UNEXPECTED |
30 |
0.0007 |
| 503 |
SCRATCH |
7 |
0.0007 |
| 504 |
HEAD INJURY |
21 |
0.0007 |
| 505 |
THERAPY CESSATION |
34 |
0.0007 |
| 506 |
CONDITION AGGRAVATED |
201 |
0.0007 |
| 507 |
END STAGE RENAL DISEASE |
12 |
0.0007 |
| 508 |
HYPERTENSION |
138 |
0.0007 |
| 509 |
COORDINATION ABNORMAL |
9 |
0.0006 |
| 510 |
SKIN LACERATION |
7 |
0.0006 |
| 511 |
DRUG INEFFECTIVE |
846 |
0.0006 |
| 512 |
PULMONARY HAEMORRHAGE |
5 |
0.0006 |
| 513 |
POISONING |
8 |
0.0006 |
| 514 |
PRODUCT PACKAGING ISSUE |
6 |
0.0006 |
| 515 |
SLEEP APNOEA SYNDROME |
12 |
0.0006 |
| 516 |
PARALYSIS |
9 |
0.0006 |
| 517 |
HYPOPHAGIA |
16 |
0.0006 |
| 518 |
GASTROINTESTINAL DISORDER |
56 |
0.0006 |
| 519 |
TRANSPLANT REJECTION |
5 |
0.0006 |
| 520 |
THERAPY NON-RESPONDER |
28 |
0.0006 |
| 521 |
CARDIAC FLUTTER |
4 |
0.0006 |
| 522 |
HEPATITIS ACUTE |
4 |
0.0006 |
| 523 |
RENAL TUBULAR NECROSIS |
6 |
0.0006 |
| 524 |
ECZEMA |
32 |
0.0006 |
| 525 |
FEELING COLD |
17 |
0.0006 |
| 526 |
PRODUCT DOSE OMISSION ISSUE |
178 |
0.0006 |
| 527 |
MENSTRUAL DISORDER |
5 |
0.0006 |
| 528 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
29 |
0.0006 |
| 529 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
27 |
0.0006 |
| 530 |
PRESCRIBED UNDERDOSE |
12 |
0.0006 |
| 531 |
DRUG DOSE OMISSION BY DEVICE |
47 |
0.0006 |
| 532 |
PRODUCT PRESCRIBING ISSUE |
13 |
0.0006 |
| 533 |
HEART RATE INCREASED |
59 |
0.0006 |
| 534 |
DIZZINESS |
297 |
0.0006 |
| 535 |
PRODUCT USE IN UNAPPROVED INDICATION |
147 |
0.0006 |
| 536 |
FEEDING DISORDER |
12 |
0.0006 |
| 537 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
10 |
0.0006 |
| 538 |
CONSTIPATION |
127 |
0.0006 |
| 539 |
DRUG DOSE OMISSION |
96 |
0.0006 |
| 540 |
POOR VENOUS ACCESS |
6 |
0.0006 |
| 541 |
DRUG INTOLERANCE |
56 |
0.0006 |
| 542 |
VENTRICULAR EXTRASYSTOLES |
6 |
0.0006 |
| 543 |
HYSTERECTOMY |
5 |
0.0006 |
| 544 |
DISCOMFORT |
35 |
0.0006 |
| 545 |
PALPITATIONS |
67 |
0.0006 |
| 546 |
VIRAL INFECTION |
19 |
0.0006 |
| 547 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
9 |
0.0006 |
| 548 |
RESPIRATORY RATE INCREASED |
5 |
0.0006 |
| 549 |
LOSS OF LIBIDO |
5 |
0.0006 |
| 550 |
DEVELOPMENTAL DELAY |
5 |
0.0006 |
| 551 |
PRODUCT PRESCRIBING ERROR |
13 |
0.0005 |
| 552 |
ORAL DISORDER |
4 |
0.0005 |
| 553 |
VENTRICULAR TACHYCARDIA |
9 |
0.0005 |
| 554 |
BLOOD PRESSURE INCREASED |
83 |
0.0005 |
| 555 |
SENSITIVE SKIN |
4 |
0.0005 |
| 556 |
ARTHROPOD BITE |
4 |
0.0005 |
| 557 |
SPEECH DISORDER |
28 |
0.0005 |
| 558 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 559 |
DISORIENTATION |
21 |
0.0005 |
| 560 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
15 |
0.0005 |
| 561 |
THERAPEUTIC RESPONSE DECREASED |
32 |
0.0005 |
| 562 |
POISONING DELIBERATE |
5 |
0.0005 |
| 563 |
DERMATITIS |
11 |
0.0005 |
| 564 |
ACIDOSIS |
4 |
0.0005 |
| 565 |
CARDIAC ARREST |
43 |
0.0005 |
| 566 |
INFLUENZA |
58 |
0.0005 |
| 567 |
FEELING ABNORMAL |
124 |
0.0005 |
| 568 |
COLD SWEAT |
9 |
0.0005 |
| 569 |
TORSADE DE POINTES |
4 |
0.0005 |
| 570 |
APPLICATION SITE RASH |
7 |
0.0005 |
| 571 |
BODY TEMPERATURE DECREASED |
5 |
0.0005 |
| 572 |
ERECTILE DYSFUNCTION |
13 |
0.0005 |
| 573 |
PRODUCT DOSE OMISSION |
33 |
0.0005 |
| 574 |
ILLNESS |
52 |
0.0005 |
| 575 |
LOW BIRTH WEIGHT BABY |
4 |
0.0005 |
| 576 |
MYOCLONUS |
6 |
0.0005 |
| 577 |
ADVERSE DRUG REACTION |
45 |
0.0005 |
| 578 |
HYPOTONIA |
5 |
0.0005 |
| 579 |
TREMOR |
83 |
0.0005 |
| 580 |
VOMITING |
235 |
0.0005 |
| 581 |
LEUKOCYTOSIS |
9 |
0.0005 |
| 582 |
ABDOMINAL PAIN UPPER |
102 |
0.0005 |
| 583 |
PRODUCT DOSE OMISSION IN ERROR |
14 |
0.0005 |
| 584 |
SCHIZOPHRENIA |
6 |
0.0005 |
| 585 |
NASAL CONGESTION |
29 |
0.0005 |
| 586 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
35 |
0.0005 |
| 587 |
DRY THROAT |
5 |
0.0005 |
| 588 |
INTENTIONAL PRODUCT USE ISSUE |
43 |
0.0005 |
| 589 |
GLOMERULAR FILTRATION RATE DECREASED |
6 |
0.0005 |
| 590 |
RIB FRACTURE |
10 |
0.0005 |
| 591 |
STAPHYLOCOCCAL INFECTION |
16 |
0.0005 |
| 592 |
NERVOUS SYSTEM DISORDER |
15 |
0.0005 |
| 593 |
PHOTOPHOBIA |
9 |
0.0005 |
| 594 |
SHOCK |
11 |
0.0005 |
| 595 |
BLOOD UREA INCREASED |
8 |
0.0005 |
| 596 |
ADVERSE EVENT |
44 |
0.0005 |
| 597 |
MIGRAINE |
45 |
0.0005 |
| 598 |
METABOLIC ACIDOSIS |
15 |
0.0005 |
| 599 |
VITAMIN D DECREASED |
4 |
0.0005 |
| 600 |
FATIGUE |
364 |
0.0005 |
| 601 |
PRODUCT CONTAINER ISSUE |
4 |
0.0005 |
| 602 |
PSEUDOMONAS INFECTION |
4 |
0.0005 |
| 603 |
HEREDITARY ANGIOEDEMA |
5 |
0.0005 |
| 604 |
HOSPITALISATION |
71 |
0.0005 |
| 605 |
CHOKING |
9 |
0.0005 |
| 606 |
HEADACHE |
289 |
0.0005 |
| 607 |
DEVICE USE ERROR |
16 |
0.0005 |
| 608 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
4 |
0.0005 |
| 609 |
INTENTIONAL PRODUCT MISUSE |
40 |
0.0005 |
| 610 |
DEVICE ADHESION ISSUE |
7 |
0.0005 |
| 611 |
DISABILITY |
9 |
0.0005 |
| 612 |
PRODUCT COMMUNICATION ISSUE |
4 |
0.0005 |
| 613 |
DEHYDRATION |
60 |
0.0004 |
| 614 |
WRONG DRUG ADMINISTERED |
4 |
0.0004 |
| 615 |
MALNUTRITION |
5 |
0.0004 |
| 616 |
DYSSTASIA |
13 |
0.0004 |
| 617 |
ANAL INCONTINENCE |
4 |
0.0004 |
| 618 |
WHITE BLOOD CELL COUNT INCREASED |
17 |
0.0004 |
| 619 |
OROPHARYNGEAL DISCOMFORT |
4 |
0.0004 |
| 620 |
EPISTAXIS |
33 |
0.0004 |
| 621 |
FEELING HOT |
27 |
0.0004 |
| 622 |
WEIGHT DECREASED |
122 |
0.0004 |
| 623 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
8 |
0.0004 |
| 624 |
UNEVALUABLE EVENT |
33 |
0.0004 |
| 625 |
INCREASED TENDENCY TO BRUISE |
4 |
0.0004 |
| 626 |
MEDICATION ERROR |
24 |
0.0004 |
| 627 |
SINUSITIS |
44 |
0.0004 |
| 628 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
20 |
0.0004 |
| 629 |
MOUTH ULCERATION |
9 |
0.0004 |
| 630 |
HYPOXIA |
15 |
0.0004 |
| 631 |
SEASONAL ALLERGY |
6 |
0.0004 |
| 632 |
DEVICE ISSUE |
38 |
0.0004 |
| 633 |
AMNESIA |
27 |
0.0004 |
| 634 |
COMPLICATION ASSOCIATED WITH DEVICE |
6 |
0.0004 |
| 635 |
FLUSHING |
42 |
0.0004 |
| 636 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 637 |
NO THERAPEUTIC RESPONSE |
5 |
0.0004 |
| 638 |
PAIN OF SKIN |
11 |
0.0004 |
| 639 |
CHRONIC KIDNEY DISEASE |
31 |
0.0004 |
| 640 |
POLLAKIURIA |
17 |
0.0004 |
| 641 |
INCORRECT DOSE ADMINISTERED |
93 |
0.0004 |
| 642 |
LIGAMENT SPRAIN |
4 |
0.0004 |
| 643 |
NIGHT SWEATS |
13 |
0.0004 |
| 644 |
ILEUS |
5 |
0.0004 |
| 645 |
UPPER LIMB FRACTURE |
8 |
0.0004 |
| 646 |
NEUROTOXICITY |
7 |
0.0004 |
| 647 |
RESPIRATORY ARREST |
11 |
0.0004 |
| 648 |
EMOTIONAL DISTRESS |
48 |
0.0004 |
| 649 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
7 |
0.0004 |
| 650 |
DIABETES MELLITUS INADEQUATE CONTROL |
7 |
0.0004 |
| 651 |
CHEST PAIN |
73 |
0.0004 |
| 652 |
MOTOR DYSFUNCTION |
4 |
0.0004 |
| 653 |
ASTHMA |
44 |
0.0004 |
| 654 |
ANAPHYLACTIC SHOCK |
10 |
0.0004 |
| 655 |
RESTLESS LEGS SYNDROME |
7 |
0.0004 |
| 656 |
DEAFNESS |
10 |
0.0004 |
| 657 |
ANHEDONIA |
10 |
0.0004 |
| 658 |
JOINT DISLOCATION |
4 |
0.0004 |
| 659 |
ADVERSE REACTION |
5 |
0.0004 |
| 660 |
BLOOD PRESSURE FLUCTUATION |
9 |
0.0004 |
| 661 |
BODY HEIGHT DECREASED |
4 |
0.0004 |
| 662 |
ABDOMINAL PAIN |
87 |
0.0004 |
| 663 |
IRRITABLE BOWEL SYNDROME |
8 |
0.0004 |
| 664 |
SINUS CONGESTION |
5 |
0.0004 |
| 665 |
TINNITUS |
17 |
0.0004 |
| 666 |
PRURITUS GENERALISED |
8 |
0.0004 |
| 667 |
DYSPHAGIA |
35 |
0.0004 |
| 668 |
OROPHARYNGEAL PAIN |
34 |
0.0004 |
| 669 |
INJECTION SITE URTICARIA |
9 |
0.0004 |
| 670 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
66 |
0.0004 |
| 671 |
EYE DISORDER |
12 |
0.0004 |
| 672 |
LOWER LIMB FRACTURE |
7 |
0.0004 |
| 673 |
GASTROINTESTINAL PAIN |
4 |
0.0004 |
| 674 |
FOOT DEFORMITY |
4 |
0.0004 |
| 675 |
LIP SWELLING |
12 |
0.0004 |
| 676 |
GAIT INABILITY |
12 |
0.0004 |
| 677 |
DRUG EFFECT INCOMPLETE |
13 |
0.0004 |
| 678 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
9 |
0.0004 |
| 679 |
PARAESTHESIA |
56 |
0.0004 |
| 680 |
EYE PAIN |
20 |
0.0004 |
| 681 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
7 |
0.0004 |
| 682 |
IMPAIRED DRIVING ABILITY |
4 |
0.0004 |
| 683 |
SCAB |
4 |
0.0004 |
| 684 |
SCAR |
6 |
0.0004 |
| 685 |
CHOLECYSTECTOMY |
4 |
0.0003 |
| 686 |
EYE SWELLING |
13 |
0.0003 |
| 687 |
NEPHROLITHIASIS |
16 |
0.0003 |
| 688 |
ABDOMINAL DISCOMFORT |
58 |
0.0003 |
| 689 |
FALL |
115 |
0.0003 |
| 690 |
NERVOUSNESS |
18 |
0.0003 |
| 691 |
HYPOKINESIA |
5 |
0.0003 |
| 692 |
HEAD DISCOMFORT |
6 |
0.0003 |
| 693 |
NAUSEA |
268 |
0.0003 |
| 694 |
RENAL INJURY |
10 |
0.0003 |
| 695 |
RHABDOMYOLYSIS |
14 |
0.0003 |
| 696 |
HYPERLIPIDAEMIA |
4 |
0.0003 |
| 697 |
HYPERSENSITIVITY |
62 |
0.0003 |
| 698 |
NASOPHARYNGITIS |
61 |
0.0003 |
| 699 |
FUNGAL INFECTION |
11 |
0.0003 |
| 700 |
ECONOMIC PROBLEM |
5 |
0.0003 |
| 701 |
ACNE |
25 |
0.0003 |
| 702 |
HYPERGLYCAEMIA |
12 |
0.0003 |
| 703 |
TOXIC EPIDERMAL NECROLYSIS |
5 |
0.0003 |
| 704 |
UNDERDOSE |
24 |
0.0003 |
| 705 |
DYSURIA |
12 |
0.0003 |
| 706 |
CARDIOMEGALY |
4 |
0.0003 |
| 707 |
HYPOKALAEMIA |
15 |
0.0003 |
| 708 |
SPINAL OPERATION |
4 |
0.0003 |
| 709 |
BRONCHITIS |
24 |
0.0003 |
| 710 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 711 |
SWELLING FACE |
21 |
0.0003 |
| 712 |
URTICARIA |
54 |
0.0003 |
| 713 |
THERAPY INTERRUPTED |
23 |
0.0003 |
| 714 |
EXTRA DOSE ADMINISTERED |
13 |
0.0003 |
| 715 |
BLOOD SODIUM DECREASED |
6 |
0.0003 |
| 716 |
RASH |
138 |
0.0003 |
| 717 |
FOOT FRACTURE |
6 |
0.0003 |
| 718 |
PNEUMOTHORAX |
5 |
0.0003 |
| 719 |
RASH MACULAR |
11 |
0.0003 |
| 720 |
ANGINA PECTORIS |
9 |
0.0003 |
| 721 |
RASH ERYTHEMATOUS |
15 |
0.0003 |
| 722 |
RASH PRURITIC |
17 |
0.0003 |
| 723 |
COVID-19 |
55 |
0.0003 |
| 724 |
VISION BLURRED |
43 |
0.0003 |
| 725 |
VERTIGO |
19 |
0.0003 |
| 726 |
DRUG RESISTANCE |
8 |
0.0003 |
| 727 |
ROAD TRAFFIC ACCIDENT |
13 |
0.0003 |
| 728 |
GASTROOESOPHAGEAL REFLUX DISEASE |
25 |
0.0003 |
| 729 |
RHINORRHOEA |
20 |
0.0003 |
| 730 |
HYPOGLYCAEMIA |
15 |
0.0003 |
| 731 |
MUSCLE TIGHTNESS |
5 |
0.0003 |
| 732 |
EAR PAIN |
6 |
0.0003 |
| 733 |
SURGERY |
18 |
0.0003 |
| 734 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
8 |
0.0003 |
| 735 |
SKIN DISCOLOURATION |
14 |
0.0003 |
| 736 |
PULMONARY CONGESTION |
4 |
0.0003 |
| 737 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 738 |
BLOOD CHOLESTEROL INCREASED |
14 |
0.0003 |
| 739 |
DRY SKIN |
40 |
0.0003 |
| 740 |
PREGNANCY |
6 |
0.0003 |
| 741 |
GASTROINTESTINAL HAEMORRHAGE |
25 |
0.0003 |
| 742 |
TYPE 2 DIABETES MELLITUS |
10 |
0.0003 |
| 743 |
ABDOMINAL DISTENSION |
31 |
0.0003 |
| 744 |
OCULAR HYPERAEMIA |
14 |
0.0003 |
| 745 |
FLUID RETENTION |
15 |
0.0003 |
| 746 |
ALANINE AMINOTRANSFERASE INCREASED |
18 |
0.0003 |
| 747 |
DEVICE DELIVERY SYSTEM ISSUE |
8 |
0.0003 |
| 748 |
MUSCULOSKELETAL DISCOMFORT |
5 |
0.0003 |
| 749 |
DEVICE DEFECTIVE |
5 |
0.0003 |
| 750 |
NEURALGIA |
7 |
0.0003 |
| 751 |
MALAISE |
126 |
0.0003 |
| 752 |
HAEMOPTYSIS |
8 |
0.0003 |
| 753 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 754 |
AMENORRHOEA |
5 |
0.0003 |
| 755 |
DEVICE OCCLUSION |
4 |
0.0003 |
| 756 |
ABASIA |
7 |
0.0003 |
| 757 |
PAIN IN JAW |
8 |
0.0003 |
| 758 |
JOINT INJURY |
6 |
0.0003 |
| 759 |
IMPAIRED WORK ABILITY |
6 |
0.0003 |
| 760 |
PNEUMONIA ASPIRATION |
7 |
0.0003 |
| 761 |
COUGH |
78 |
0.0003 |
| 762 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 763 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
6 |
0.0003 |
| 764 |
PRODUCT COMPLAINT |
7 |
0.0003 |
| 765 |
INJECTION SITE REACTION |
19 |
0.0003 |
| 766 |
CHOLELITHIASIS |
9 |
0.0003 |
| 767 |
RESPIRATORY FAILURE |
20 |
0.0003 |
| 768 |
IMPAIRED HEALING |
9 |
0.0003 |
| 769 |
CHEST DISCOMFORT |
28 |
0.0003 |
| 770 |
INJECTION SITE MASS |
10 |
0.0003 |
| 771 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
4 |
0.0003 |
| 772 |
CONTUSION |
26 |
0.0003 |
| 773 |
STEVENS-JOHNSON SYNDROME |
6 |
0.0003 |
| 774 |
CONJUNCTIVITIS |
5 |
0.0003 |
| 775 |
IMMUNODEFICIENCY |
4 |
0.0003 |
| 776 |
BACTERIAL INFECTION |
5 |
0.0003 |
| 777 |
HEPATIC FUNCTION ABNORMAL |
10 |
0.0003 |
| 778 |
EYE PRURITUS |
9 |
0.0003 |
| 779 |
RASH PAPULAR |
6 |
0.0003 |
| 780 |
RESPIRATORY DISORDER |
8 |
0.0003 |
| 781 |
MUSCLE SPASMS |
49 |
0.0003 |
| 782 |
PANCREATITIS ACUTE |
6 |
0.0003 |
| 783 |
TUBULOINTERSTITIAL NEPHRITIS |
5 |
0.0003 |
| 784 |
CONFUSIONAL STATE |
43 |
0.0003 |
| 785 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 786 |
APHASIA |
8 |
0.0003 |
| 787 |
PANCREATITIS |
14 |
0.0003 |
| 788 |
RENAL FAILURE |
35 |
0.0003 |
| 789 |
INJECTION SITE SWELLING |
20 |
0.0003 |
| 790 |
UPPER RESPIRATORY TRACT INFECTION |
12 |
0.0003 |
| 791 |
PERIPHERAL SWELLING |
40 |
0.0003 |
| 792 |
GLAUCOMA |
5 |
0.0003 |
| 793 |
LIMB DISCOMFORT |
8 |
0.0003 |
| 794 |
OEDEMA |
14 |
0.0003 |
| 795 |
LIMB INJURY |
7 |
0.0003 |
| 796 |
RENAL DISORDER |
12 |
0.0003 |
| 797 |
ORAL HERPES |
5 |
0.0003 |
| 798 |
PRURITUS |
98 |
0.0003 |
| 799 |
SICKLE CELL ANAEMIA WITH CRISIS |
4 |
0.0003 |
| 800 |
ABNORMAL DREAMS |
7 |
0.0003 |
| 801 |
ASTHENIA |
95 |
0.0003 |
| 802 |
SINUS DISORDER |
5 |
0.0003 |
| 803 |
CATARACT |
15 |
0.0003 |
| 804 |
INFLAMMATION |
13 |
0.0003 |
| 805 |
BLOOD PRESSURE ABNORMAL |
5 |
0.0003 |
| 806 |
PYREXIA |
87 |
0.0003 |
| 807 |
OXYGEN SATURATION DECREASED |
14 |
0.0002 |
| 808 |
LOCALISED INFECTION |
6 |
0.0002 |
| 809 |
ADRENAL INSUFFICIENCY |
3 |
0.0002 |
| 810 |
FLATULENCE |
14 |
0.0002 |
| 811 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 812 |
BACK DISORDER |
4 |
0.0002 |
| 813 |
PRODUCT PREPARATION ERROR |
5 |
0.0002 |
| 814 |
PHOTOSENSITIVITY REACTION |
4 |
0.0002 |
| 815 |
LOWER RESPIRATORY TRACT INFECTION |
11 |
0.0002 |
| 816 |
EXPIRED PRODUCT ADMINISTERED |
8 |
0.0002 |
| 817 |
DRY EYE |
12 |
0.0002 |
| 818 |
GAIT DISTURBANCE |
46 |
0.0002 |
| 819 |
CARDIO-RESPIRATORY ARREST |
10 |
0.0002 |
| 820 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0002 |
| 821 |
FACE OEDEMA |
4 |
0.0002 |
| 822 |
TRANSIENT ISCHAEMIC ATTACK |
8 |
0.0002 |
| 823 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
8 |
0.0002 |
| 824 |
CARDIAC FAILURE |
19 |
0.0002 |
| 825 |
HEPATIC ENZYME INCREASED |
16 |
0.0002 |
| 826 |
GENERAL PHYSICAL HEALTH DETERIORATION |
27 |
0.0002 |
| 827 |
MEMORY IMPAIRMENT |
32 |
0.0002 |
| 828 |
BLOOD POTASSIUM DECREASED |
7 |
0.0002 |
| 829 |
RASH GENERALISED |
6 |
0.0002 |
| 830 |
BLISTER |
13 |
0.0002 |
| 831 |
INJECTION SITE PAIN |
71 |
0.0002 |
| 832 |
OEDEMA PERIPHERAL |
28 |
0.0002 |
| 833 |
ACUTE KIDNEY INJURY |
35 |
0.0002 |
| 834 |
PNEUMONIA |
74 |
0.0002 |
| 835 |
DRUG WITHDRAWAL SYNDROME |
20 |
0.0002 |
| 836 |
DEVICE DIFFICULT TO USE |
15 |
0.0002 |
| 837 |
ASPARTATE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 838 |
EYE IRRITATION |
13 |
0.0002 |
| 839 |
SKIN EXFOLIATION |
19 |
0.0002 |
| 840 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 841 |
SWOLLEN TONGUE |
7 |
0.0002 |
| 842 |
MENSTRUATION IRREGULAR |
6 |
0.0002 |
| 843 |
ORAL PAIN |
5 |
0.0002 |
| 844 |
SNEEZING |
5 |
0.0002 |
| 845 |
GOUT |
4 |
0.0002 |
| 846 |
DYSPHONIA |
13 |
0.0002 |
| 847 |
TOOTHACHE |
4 |
0.0002 |
| 848 |
PAIN IN EXTREMITY |
65 |
0.0002 |
| 849 |
HYPOAESTHESIA |
33 |
0.0002 |
| 850 |
MUSCULAR WEAKNESS |
25 |
0.0002 |
| 851 |
CYSTITIS |
7 |
0.0002 |
| 852 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 853 |
DIARRHOEA |
141 |
0.0002 |
| 854 |
HAEMATOCHEZIA |
12 |
0.0002 |
| 855 |
SWELLING |
20 |
0.0002 |
| 856 |
ACCIDENTAL EXPOSURE TO PRODUCT |
22 |
0.0002 |
| 857 |
DYSPEPSIA |
21 |
0.0002 |
| 858 |
HOT FLUSH |
16 |
0.0002 |
| 859 |
WHITE BLOOD CELL COUNT DECREASED |
23 |
0.0002 |
| 860 |
PRODUCTIVE COUGH |
10 |
0.0002 |
| 861 |
HERPES ZOSTER |
12 |
0.0002 |
| 862 |
BALANCE DISORDER |
18 |
0.0002 |
| 863 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 864 |
LIVER FUNCTION TEST ABNORMAL |
6 |
0.0002 |
| 865 |
NEEDLE ISSUE |
6 |
0.0002 |
| 866 |
URINARY TRACT INFECTION |
35 |
0.0002 |
| 867 |
CHILLS |
24 |
0.0002 |
| 868 |
CEREBRAL INFARCTION |
5 |
0.0002 |
| 869 |
KIDNEY INFECTION |
4 |
0.0002 |
| 870 |
LIVER DISORDER |
9 |
0.0002 |
| 871 |
DYSGEUSIA |
15 |
0.0002 |
| 872 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 873 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
5 |
0.0002 |
| 874 |
COMPLICATION OF DEVICE INSERTION |
4 |
0.0002 |
| 875 |
INFECTION |
29 |
0.0002 |
| 876 |
ANAPHYLACTIC REACTION |
11 |
0.0002 |
| 877 |
LYMPHADENOPATHY |
7 |
0.0002 |
| 878 |
ILL-DEFINED DISORDER |
12 |
0.0002 |
| 879 |
HAEMATEMESIS |
5 |
0.0002 |
| 880 |
NECK PAIN |
11 |
0.0002 |
| 881 |
BODY TEMPERATURE INCREASED |
4 |
0.0002 |
| 882 |
ERYTHEMA |
40 |
0.0002 |
| 883 |
VISUAL IMPAIRMENT |
24 |
0.0002 |
| 884 |
SKIN ULCER |
5 |
0.0002 |
| 885 |
DRUG DEPENDENCE |
31 |
0.0002 |
| 886 |
RESPIRATORY TRACT INFECTION |
5 |
0.0002 |
| 887 |
BLOOD GLUCOSE INCREASED |
36 |
0.0002 |
| 888 |
DYSPNOEA |
108 |
0.0002 |
| 889 |
RENAL IMPAIRMENT |
16 |
0.0002 |
| 890 |
GASTRITIS |
5 |
0.0002 |
| 891 |
DISEASE RECURRENCE |
9 |
0.0002 |
| 892 |
INTESTINAL OBSTRUCTION |
7 |
0.0002 |
| 893 |
DIABETES MELLITUS |
14 |
0.0002 |
| 894 |
INTERVERTEBRAL DISC PROTRUSION |
4 |
0.0002 |
| 895 |
INFLUENZA LIKE ILLNESS |
15 |
0.0002 |
| 896 |
STOMATITIS |
11 |
0.0002 |
| 897 |
RESPIRATORY DISTRESS |
5 |
0.0002 |
| 898 |
PROCEDURAL PAIN |
5 |
0.0002 |
| 899 |
CHROMATURIA |
4 |
0.0002 |
| 900 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 901 |
BACK PAIN |
41 |
0.0002 |
| 902 |
BLINDNESS |
7 |
0.0002 |
| 903 |
INJURY |
12 |
0.0002 |
| 904 |
CEREBRAL HAEMORRHAGE |
6 |
0.0002 |
| 905 |
MOBILITY DECREASED |
12 |
0.0002 |
| 906 |
BLOOD GLUCOSE DECREASED |
8 |
0.0002 |
| 907 |
HEPATIC FAILURE |
5 |
0.0002 |
| 908 |
ARTHRITIS |
13 |
0.0002 |
| 909 |
FIBROMYALGIA |
4 |
0.0002 |
| 910 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 911 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 912 |
HYPOACUSIS |
7 |
0.0002 |
| 913 |
NEUTROPENIA |
22 |
0.0002 |
| 914 |
SEPTIC SHOCK |
7 |
0.0002 |
| 915 |
AGEUSIA |
4 |
0.0002 |
| 916 |
CARDIAC DISORDER |
15 |
0.0002 |
| 917 |
MUSCULOSKELETAL STIFFNESS |
14 |
0.0002 |
| 918 |
ANGIOEDEMA |
7 |
0.0002 |
| 919 |
NEUROPATHY PERIPHERAL |
15 |
0.0002 |
| 920 |
PAIN |
96 |
0.0002 |
| 921 |
HAEMATOMA |
4 |
0.0002 |
| 922 |
EXPOSURE VIA SKIN CONTACT |
4 |
0.0002 |
| 923 |
INJECTION SITE ERYTHEMA |
19 |
0.0002 |
| 924 |
SKIN IRRITATION |
7 |
0.0002 |
| 925 |
SKIN DISORDER |
5 |
0.0001 |
| 926 |
JAUNDICE |
4 |
0.0001 |
| 927 |
FREQUENT BOWEL MOVEMENTS |
4 |
0.0001 |
| 928 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 929 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 930 |
PSORIASIS |
19 |
0.0001 |
| 931 |
ARTHRALGIA |
60 |
0.0001 |
| 932 |
DRUG ABUSE |
12 |
0.0001 |
| 933 |
ARTHROPATHY |
8 |
0.0001 |
| 934 |
LUNG DISORDER |
7 |
0.0001 |
| 935 |
DEVICE MALFUNCTION |
10 |
0.0001 |
| 936 |
RENAL FAILURE ACUTE |
6 |
0.0001 |
| 937 |
DEVICE DISLOCATION |
6 |
0.0001 |
| 938 |
DYSPNOEA EXERTIONAL |
5 |
0.0001 |
| 939 |
CONTRAINDICATED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 940 |
INJECTION SITE RASH |
4 |
0.0001 |
| 941 |
MYALGIA |
22 |
0.0001 |
| 942 |
EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 943 |
PULMONARY EMBOLISM |
12 |
0.0001 |
| 944 |
PRODUCT STORAGE ERROR |
11 |
0.0001 |
| 945 |
SEPSIS |
14 |
0.0001 |
| 946 |
ABORTION SPONTANEOUS |
5 |
0.0001 |
| 947 |
PSORIATIC ARTHROPATHY |
5 |
0.0001 |
| 948 |
FOETAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 949 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 950 |
WHEEZING |
7 |
0.0001 |
| 951 |
OSTEOARTHRITIS |
5 |
0.0001 |
| 952 |
ALOPECIA |
23 |
0.0001 |
| 953 |
GASTRIC DISORDER |
4 |
0.0001 |
| 954 |
BURNING SENSATION |
8 |
0.0001 |
| 955 |
HYPERKALAEMIA |
4 |
0.0001 |
| 956 |
CARDIAC FAILURE CONGESTIVE |
9 |
0.0001 |
| 957 |
COLITIS ULCERATIVE |
5 |
0.0001 |
| 958 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 959 |
THROAT IRRITATION |
5 |
0.0001 |
| 960 |
DEVICE EXPULSION |
7 |
0.0001 |
| 961 |
INJECTION SITE PRURITUS |
7 |
0.0001 |
| 962 |
CEREBROVASCULAR ACCIDENT |
17 |
0.0001 |
| 963 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
| 964 |
CELLULITIS |
5 |
0.0001 |
| 965 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 966 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
5 |
0.0001 |
| 967 |
HAEMORRHAGE |
10 |
0.0001 |
| 968 |
MUSCULOSKELETAL PAIN |
5 |
0.0001 |
| 969 |
DISEASE PROGRESSION |
11 |
0.0001 |
| 970 |
ATRIAL FIBRILLATION |
9 |
0.0001 |
| 971 |
DEEP VEIN THROMBOSIS |
6 |
0.0001 |
| 972 |
VAGINAL HAEMORRHAGE |
4 |
0.0001 |
| 973 |
INFUSION RELATED REACTION |
6 |
0.0001 |
| 974 |
PANCYTOPENIA |
5 |
0.0001 |
| 975 |
ANAEMIA |
17 |
0.0001 |
| 976 |
HYPONATRAEMIA |
5 |
0.0001 |
| 977 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 978 |
MATERNAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 979 |
INJECTION SITE BRUISING |
6 |
0.0001 |
| 980 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 981 |
THROMBOSIS |
6 |
0.0001 |
| 982 |
JOINT SWELLING |
9 |
0.0001 |
| 983 |
MYOCARDIAL INFARCTION |
12 |
0.0001 |
| 984 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 985 |
DEATH |
55 |
0.0001 |
| 986 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 987 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 988 |
RHEUMATOID ARTHRITIS |
5 |
0.0000 |